Nobuyuki Miyasaka Selected Research

Nobuyuki Miyasaka Research Topics

Disease

104	Rheumatoid Arthritis 03/2021 - 10/2002
19	Arthritis (Polyarthritis) 02/2016 - 10/2002
14	Infections 01/2021 - 01/2007
14	Inflammation (Inflammations) 01/2019 - 06/2004
13	Polymyositis 01/2018 - 12/2003
12	Dermatomyositis (Dermatopolymyositis) 01/2020 - 06/2002
11	Myositis (Idiopathic Inflammatory Myopathies) 01/2018 - 04/2007
11	Experimental Arthritis 01/2016 - 10/2002
10	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2020 - 01/2005
9	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2020 - 06/2002
4	Rheumatic Diseases (Rheumatism) 01/2020 - 10/2011
4	Vasculitis (Vasculitides) 01/2019 - 02/2013
4	Autoimmune Diseases (Autoimmune Disease) 01/2016 - 02/2008
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2016 - 01/2007
3	Necrosis 01/2020 - 07/2011
3	Neoplasms (Cancer) 09/2016 - 02/2008
3	Drug-Related Side Effects and Adverse Reactions 01/2016 - 06/2012
3	Lupus Nephritis 01/2016 - 09/2003
3	Opportunistic Infections (Opportunistic Infection) 11/2012 - 01/2005
2	Churg-Strauss Syndrome (Allergic Angiitis) 04/2019 - 07/2014
2	Herpes Zoster 09/2018 - 01/2017
2	Fever (Fevers) 01/2016 - 01/2015
2	Crohn Disease (Crohn's Disease) 01/2016 - 09/2014
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2016 - 10/2012
2	Osteoarthritis 10/2014 - 11/2002
2	Hepatitis 01/2014 - 01/2008
2	Immunoglobulin G4-Related Disease 11/2013 - 08/2011
2	Retroperitoneal Fibrosis 11/2013 - 08/2011
2	Glomerulonephritis 07/2013 - 12/2010
2	Bacterial Infections (Bacterial Infection) 06/2013 - 06/2009
2	Lung Diseases (Lung Disease) 11/2012 - 11/2012
2	Nephritis 12/2010 - 01/2009

Drug/Important Bio-Agent (IBA)

29	Methotrexate (Mexate)FDA LinkGeneric 03/2020 - 01/2006
21	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 12/2004
19	Biological ProductsIBA 09/2018 - 01/2006
17	Antirheumatic Agents (DMARD)IBA 09/2018 - 09/2007
16	Infliximab (Remicade)FDA Link 01/2020 - 01/2005
15	Etanercept (Enbrel)FDA Link 03/2021 - 01/2005
13	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2002
12	tocilizumab (atlizumab)FDA Link 05/2020 - 09/2007
12	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2018 - 09/2003
12	Adalimumab (Humira)FDA Link 01/2017 - 01/2008
12	CytokinesIBA 02/2015 - 11/2002
10	Tacrolimus (Prograf)FDA LinkGeneric 01/2021 - 02/2008
10	Interleukin-6 (Interleukin 6)IBA 01/2016 - 06/2004
9	Certolizumab Pegol FDA Link 03/2020 - 07/2014
8	Prednisolone (Predate)FDA LinkGeneric 01/2020 - 06/2002
8	Tumor Necrosis Factor InhibitorsIBA 09/2018 - 01/2009
7	AntibodiesIBA 01/2017 - 12/2002
6	Pharmaceutical PreparationsIBA 05/2021 - 06/2012
6	golimumab FDA Link 09/2018 - 06/2012
6	Abatacept (Orencia)FDA Link 09/2017 - 03/2013
6	Therapeutic UsesIBA 07/2017 - 01/2005
6	ChemokinesIBA 02/2015 - 01/2009
6	LigandsIBA 09/2014 - 11/2002
6	Monoclonal AntibodiesIBA 03/2014 - 10/2005
5	AutoantibodiesIBA 01/2017 - 12/2002
5	Intravenous Immunoglobulins (IVIG)FDA Link 07/2015 - 12/2003
5	Immunoglobulin G (IgG)IBA 08/2014 - 12/2002
5	Collagen Type II (Type II Collagen)IBA 08/2014 - 10/2002
4	C-Reactive ProteinIBA 01/2021 - 06/2013
4	GlucocorticoidsIBA 01/2020 - 01/2009
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2019 - 01/2008
4	Immunosuppressive Agents (Immunosuppressants)IBA 04/2019 - 08/2005
4	Interleukin-17 (Interleukin 17)IBA 01/2016 - 08/2009
4	Rituximab (Mabthera)FDA Link 01/2016 - 01/2007
4	Biomarkers (Surrogate Marker)IBA 05/2015 - 01/2009
4	Messenger RNA (mRNA)IBA 10/2014 - 03/2002
4	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2012 - 11/2003
3	lysophosphatidic acidIBA 01/2019 - 08/2013
3	Lysophosphatidic Acid ReceptorsIBA 01/2019 - 08/2013
3	Peptides (Polypeptides)IBA 07/2017 - 07/2015
3	RetinoidsIBA 02/2013 - 10/2009
3	tamibaroteneIBA 02/2013 - 10/2009
3	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 11/2012 - 07/2006
3	Chemokine CX3CL1IBA 03/2012 - 12/2004
3	SteroidsIBA 01/2008 - 06/2002
2	Trimethoprim (Proloprim)FDA LinkGeneric 01/2020 - 01/2017
2	Thymidine Monophosphate (TMP)IBA 01/2020 - 01/2017
2	Sulfamethoxazole FDA LinkGeneric 01/2020 - 01/2017
2	LipidsIBA 01/2019 - 08/2013
2	AutoantigensIBA 07/2017 - 07/2015
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 07/2017 - 07/2015
2	CollagenIBA 02/2016 - 10/2015
2	InterleukinsIBA 01/2016 - 06/2010
2	Interleukin-4 (Interleukin 4)IBA 01/2016 - 10/2009
2	InterferonsIBA 01/2016 - 06/2010
2	Peptide Hydrolases (Proteases)FDA Link 01/2016 - 11/2003
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2016 - 10/2012
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2015 - 08/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2014 - 01/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 12/2002
2	Complement System Proteins (Complement)IBA 11/2013 - 01/2009
2	Cyclin-Dependent Kinase Inhibitor p16IBA 11/2012 - 07/2006
2	Creatine Kinase (Creatine Phosphokinase)IBA 06/2012 - 12/2003
2	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 04/2011 - 01/2005
2	Myosins (Myosin)IBA 10/2009 - 11/2005

Therapy/Procedure

35	Therapeutics 03/2020 - 06/2002
2	Intraperitoneal Injections 04/2017 - 02/2013
2	Biological Therapy 05/2015 - 11/2012